|
|
谢晶日教授辨治克罗恩病药对探妙
|
Abstract:
克罗恩病是一种病因尚未明确的慢性炎性肉芽肿性疾病，可累及多段消化道，目前现代医学对其仍无较好的治疗效果。谢晶日教授从事消化系统疾病的防治四十余年，积累了丰富经验。谢晶日教授认为克罗恩病是脾虚胃弱、肝气郁滞，大肠传导失主，水走肠间，清浊相干而不分，气机阻结一处，脉络失和，肉腐血败而致本病。在治疗时强调以理脾化湿为重点，同时在克罗恩病的各个病理阶段辨证论治，总结了较多临床疗效出众的药对。笔者有幸跟随谢师在门诊学习，现将谢晶日教授治疗克罗恩病的经验与药对做出浅析。
Crohn’s disease is a chronic inflammatory granulomatous disease with unknown etiology, which can involve multiple digestive tracts. At present, modern medicine still has no good therapeutic effect on it. Professor Xie Jingri has been engaged in the treatment and prevention of digestive system diseases for more than forty years, and has accumulated rich experience. Professor Xie Jingri believes that Crohn’s disease is caused by spleen deficiency, weak stomach, stagnation of liver qi, loss of conduction in large intestine, water passing between intestines, turbid and coherent, stagnation of qi, disharmony of veins, meat rot and blood failure. Emphasis is placed on regulating spleen and eliminating dampness in treatment, and at the same time, syndrome differentiation and treatment are carried out in various pathological stages of Crohn’s disease, and many drug pairs with outstanding clinical effects are summarized. The author is fortunate to study with Xie Shi in the outpatient clinic. Now, I will analyze Professor Xie Jingri’s experience and drug pair in treating Crohn’s disease.
| [1] | Adamina, M., Bonovas, S., Raine, T., Spinelli, A., Warusavitarne, J., Armuzzi, A., et al. (2019) ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment. Journal of Crohn’s and Colitis, 14, 155-168. https://doi.org/10.1093/ecco-jcc/jjz187 |
| [2] | Rajbhandari, R., Blakemore, S., Gupta, N., Mannan, S., Nikolli, K., Yih, A., et al. (2022) Crohn’s Disease among the Poorest Billion: Burden of Crohn’s Disease in Low-and Lower-Middle-Income Countries. Digestive Diseases and Sciences, 68, 1226-1236. https://doi.org/10.1007/s10620-022-07675-6 |
| [3] | 吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年？北京) [J]. 中国实用内科杂志, 2018, 38(9): 796-813. |
| [4] | de Groof, E.J., Stevens, T.W., Eshuis, E.J., Gardenbroek, T.J., Bosmans, J.E., van Dongen, J., et al. (2019) Cost-Effectiveness of Laparoscopic Ileocaecal Resection versus Infliximab Treatment of Terminal Ileitis in Crohn’s Disease: The LIR!C Trial. Gut, 68, 1774-1780. https://doi.org/10.1136/gutjnl-2018-317539 |
| [5] | Zangenberg, M.S., Horesh, N., Kopylov, U. and El-Hussuna, A. (2017) Preoperative Optimization of Patients with Inflammatory Bowel Disease Undergoing Gastrointestinal Surgery: A Systematic Review. International Journal of Colorectal Disease, 32, 1663-1676. https://doi.org/10.1007/s00384-017-2915-4 |
| [6] | 史佳宁, 郝微微, 温红珠, 等. 健脾化湿法治疗克罗恩病1例[J]. 中医杂志, 2017, 58(1): 84-85. |
| [7] | 李娜, 郝旭蕊, 李维康, 等. 刘启泉从肝脾论治溃疡性结肠炎经验浅析[J]. 中华中医药杂志, 2020, 35(2): 735-737. |
| [8] | 鲁军, 胡聿昕, 揭阳, 等. 补益之品“闭门留寇”与“扶正祛邪”矛盾浅析[J]. 浙江中医药大学学报, 2020, 44(10): 953-955. |
| [9] | 黄媛, 胡佩欣, 周升凤, 等. 中医外治法在炎症性肠病中的应用进展[J]. 广东医学, 2022, 43(5): 657-660. |
| [10] | 李晓凯, 顾坤, 梁慕文, 张胤弢, 王玉明, 李遇伯. 薏苡仁化学成分及药理作用研究进展[J]. 中草药, 2020, 51(21): 5645-5657. |
| [11] | 杜航, 何文生, 胡红兰, 等. 白术活性成分药理作用研究进展[J]. 江苏中医药, 2022, 54(5): 76-80. |
| [12] | Zhang, W.K., Tao, S., Li, T., Li, Y., Li, X., Tang, H., et al. (2016) Nutmeg Oil Alleviates Chronic Inflammatory Pain through Inhibition of COX-2 Expression and Substance P Release in vivo. Food & Nutrition Research, 60, Article 30849. https://doi.org/10.3402/fnr.v60.30849 |
| [13] | 肖雯雯, 万仁山, 张红林, 等. 肉豆蔻化学成分及抗炎活性研究[J]. 云南中医药大学学报, 2023, 46(5): 66-73. |
| [14] | 杨婷, 杨学军, 邓芳, 李顺祥. 补骨脂化学成分研究及其质量标志物预测分析[J]. 湖南中医杂志, 2023, 39(8): 141-149. |
| [15] | 付琳, 付强, 李冀, 等. 黄连化学成分及药理作用研究进展[J]. 中医药学报, 2021, 49(2): 87-92. |
| [16] | Zhang, J., Zhou, R., Xiang, C., Jia, Q., Wu, H. and Yang, H. (2020) Huangbai Liniment Accelerated Wound Healing by Activating Nrf2 Signaling in Diabetes. Oxidative Medicine and Cellular Longevity, 2020, Article 4951820. https://doi.org/10.1155/2020/4951820 |
| [17] | 王玲, 杜潇, 祝华莲, 等. 黄柏有效成分的药理作用研究进展[J]. 江苏中医药, 2022, 54(4): 77-81. |
| [18] | 王海强, 周千瑶, 李冰琪, 等. 柴胡化学成分及药理作用研究进展[J]. 吉林中医药, 2024, 44(1): 96-100. |
| [19] | 汪晓辉, 郭溶, 聂晓彬, 等. 佛手抗菌活性及其药效成分橙皮苷对金黄色葡萄球菌的作用机制研究[J]. 中国抗生素杂志, 2021, 46(5): 437-441. |
| [20] | 史俊豪, 丘琴, 刘晓芳, 等. 佛手化学成分和药理作用及其质量标志物(Q-Marker)预测分析[J]. 中华中医药学刊, 2023, 41(4): 17-28. |
| [21] | Leite, C.d.S., Bonafé, G.A., Carvalho Santos, J., Martinez, C.A.R., Ortega, M.M. and Ribeiro, M.L. (2022) The Anti-Inflammatory Properties of Licorice (Glycyrrhiza glabra)-Derived Compounds in Intestinal Disorders. International Journal of Molecular Sciences, 23, Article 4121. https://doi.org/10.3390/ijms23084121 |
| [22] | 代倩倩, 夏欢, 夏桂阳, 等. 白芍方药以及白芍总苷镇痛功效及其机理研究进展[J]. 世界科学技术-中医药现代化, 2020, 22(1): 39-46. |
| [23] | Cao, X., Ni, J., Wang, X., Feng, G., Li, H., Bao, W., et al. (2021) Total Glucosides of Paeony Restores Intestinal Barrier Function through Inhibiting Lyn/Snail Signaling Pathway in Colitis Mice. Phytomedicine, 87, Article 153590. https://doi.org/10.1016/j.phymed.2021.153590 |
| [24] | 哈瑞雯, 周海燕, 詹志来, 等. 乳香化学成分、药理作用研究进展及质量标志物的预测分析[J]. 中华中医药学刊, 2021, 39(11): 94-107. |
| [25] | 杨宝, 徐莲莲, 陈芳有, 罗永明. 没药化学成分及抗炎活性研究[J]. 中草药, 2023, 54(9): 2716-2721. |
| [26] | 石礼平, 张国壮, 刘丛盛, 等. 三七化学成分和药理作用研究概况及质量标志物的预测[J]. 中国中药杂志, 2023, 48(8): 2059-2067. |
| [27] | 马艳春, 胡建辉, 吴文轩, 等. 黄芪化学成分及药理作用研究进展[J]. 中医药学报, 2022, 50(4): 92-95. |
| [28] | 梁啸, 李亚楠, 王志娜, 等. 马齿苋物质基础及其药理活性研究进展[J]. 辽宁大学学报(自然科学版), 2023, 50(4): 373-384. |
| [29] | 苏晓悦, 徐驰, 杜鑫, 等. 白头翁化学成分及其药理作用研究进展[J]. 中医药信息, 2023, 40(3): 76-82. |
